Dr Sara Tolaney
Medical Oncologist
Dana-Farber Cancer Institute and Harvard Medical School, US
United States
More information
New oral endocrine therapy options in breast cancer
-
Tuesday, 20th June, 2023
-
13:30h
-
16:00h
(UTC)
United States
More information
Dr Aditya Bardia
Medical Oncologist
Harvard Medical School, US
United States
More information
Prof. Frédérique Penault-Llorca
Pathologist
University of Clermont-Ferrand, France
France
More information
A virtual Experts Knowledge Share on the topic ‘New oral endocrine therapy options in breast cancer’ chaired by Dr Sara Tolaney (US) and co-chaired by Dr Aditya Bardia (US) and Prof. Frederique Penault-Llorca (France).
Learn about and discuss:
- Oral SERDs efficacy and safety profiles in patients with ER+/HER2- advanced or metastatic breast cancer and their place in treatment landscape
- How to optimize treatment selection and sequencing in ER+/HER2- advanced or metastatic breast cancer
- Why, when and how to test for ESR1 mutation in patients with ER+/HER2- advanced or metastatic breast cancer
This event is in collaboration with BREAST CANCER CONNECT, a group of international experts in breast cancer.
You will also have the opportunity to contribute to the discussion on this important topic. If you would like to submit a question for the Scientific Committee, please send them to selina.gill@cor2ed.com
Brought to you by
BREAST CANCER CONNECT is an initiative of COR2ED. This programme is endorsed by GRASP & SOLTI. This programme is supported by an Independent Medical Education Grant from Menarini Stemline Oncology
Other events of your interest
Expert Knowledge Share
Oncology
The evolving TROP2-directed ADC landscape in metastatic NSCLC and strategies to optimise the treatment experience
-
11th May, 2026
-
16:30h
-
17:45h
UTC
The Role of PARPi in Prostate Cancer: Experts Knowledge Share
-
28th August, 2020
-
16:30h
-
18:00h
UTC